NCT01368419View on ClinicalTrials.gov

Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Esophageal Cancer
Interventions
DRUG

Endostar

75mg Endostar in 235mL normal saline, 24h continuous infusion, 6 weeks

RADIATION

Radiotherapy

6～15MV X-ray, 2Gy/time，5times/week，6 weeks

Trial Locations (1)

222002

RECRUITING

The First People's Hospital of Lianyungang, Lianyungang

Sponsors
All Listed Sponsors
collaborator

The First People's Hospital of Lianyungang

OTHER

lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY